HIV-free Survival Among Breastfed Infants Born to HIV-positive Women in Northern Uganda: a Facility-based Retrospective Study
Overview
Affiliations
Introduction: the HIV-free survival rate is the gold-standard measure of the effectiveness of interventions towards prevention of mother-to-child transmission of HIV in any setting. However, data on HIV-free survival among the HIV-exposed infants followed up in most low-resource settings are lacking. We determined the HIV-free survival among breastfed infants in two tertiary facilities in a resource-poor setting in northern Uganda.
Methods: we conducted a retrospective cohort study in May 2019 and retrospectively reviewed records of HIV-exposed infants registered in 2014 through 2016 at two tertiary facilities in northern Uganda. We analyzed data using SPSS v16 software package. The chi-square and Student t-tests were used to compare factors among infant groups. Multivariate logistic regression analysis was used to determine factors independently associated with HIV-free survival. P-value <0.05 was considered for statistical significance.
Results: majority of the infants were males 55.6% (203/365) and 98.6% (360/365) received nevirapine prophylaxis. A total of 345 (94.5%) infants were exclusively breastfed, only 100/345 (29.0%) of whom were exclusively breastfed for at least 6 months, while the breastfeeding status of 44/345 (12.8 %) infants could not be ascertained. The overall HIV-free survival rate was 93.7% (342/365), while 2.7% (10/365) were HIV-infected and 3.6% (13/365) died. Infants´ age at enrolment in care (aOR 5.20, p=0.008) and treatment facility (aOR 3.76, p=0.027) were the independent determinants of HIV-free survival.
Conclusion: the HIV-free survival rate among the breastfed infants in the study setting marginally falls short of the recommended standard, thus calling for more efforts to improve survival.
Gedefaw A, Tadesse B, Tadesse S, Kebede B, Hussen S, Hailu D BMC Public Health. 2024; 24(1):3367.
PMID: 39627710 PMC: 11613881. DOI: 10.1186/s12889-024-20761-w.
Belete N, Megersa N, Hebo S, Animut M, Tariku E BMC Pediatr. 2024; 24(1):410.
PMID: 38926639 PMC: 11202369. DOI: 10.1186/s12887-024-04894-w.